Literature DB >> 1807366

Etiologic considerations of nonspecific pleuritis.

N J Kim1, S C Hong, J O Kim, J W Suhr, S Y Kim, H K Ro.   

Abstract

Twenty-three patients with nonspecific pleuritis were studied to determine clinical outcome. After a mean follow-up period of 6 months (1 to 36 months), a diagnosis was reached in 17 patients, while 6 patients remained unknown. The causes of the nonspecific pleuritis diagnosed on initial pleural biopsy were tuberculosis (11 patients, 48%), neoplasm (2 patients, 8.7%), parapneumonic effusion (1 patient), subphrenic abscess (1 patient), congestive heart failure (1 patients), and nephrotic syndrome (1 patient). The diagnosis was made by therapeutic trials (tuberculosis: 11 patients, parapneumonic effusion: 1 patient, congestive heart failure: 1 patient), by repeat pleural biopsy in 1 hepatoma, by open thoractomy in 1 lung cancer, by exploratory laparotomy in 1 subphrenic abscess, and by kidney biopsy in 1 nephrotic syndrome. The WBC counts (more than 2,000/mm3) and lymphocyte percentage (more than 60%) in the pleural fluid were significantly elevated in the patients with tuberculosis compared to those with malignant pleurisy, and other laboratory data were meaningless. As a result of this investigation, we suggest that tuberculous pleurisy is the most common cause of nonspecific pleuritis in Korea and that therapeutic trial with antituberculous medication for patients with high WBC count and lymphocyte percent in pleural fluid can help to locate the nonspecific pleuritis.

Entities:  

Mesh:

Year:  1991        PMID: 1807366      PMCID: PMC4532121          DOI: 10.3904/kjim.1991.6.2.58

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   2.884


  27 in total

1.  Sugar levels in pleural effusions of different etiologies.

Authors:  J GLENERT
Journal:  Acta Tuberc Pneumol Scand       Date:  1962

2.  Glucose level in pleural fluid as a diagnostic aid.

Authors:  L M BARBER; L MAZZADI; D D DEAKINS; C N REESE; W L ROGERS
Journal:  Dis Chest       Date:  1957-06

3.  Pleural effusion; a statistical study of 436 patients.

Authors:  E C LEUALLEN; D T CARR
Journal:  N Engl J Med       Date:  1955-01-20       Impact factor: 91.245

4.  Carcinomatous involvement of the pleura: an analysis of 96 patients.

Authors:  B Chernow; S A Sahn
Journal:  Am J Med       Date:  1977-11       Impact factor: 4.965

5.  Low glucose and pH levels in malignant pleural effusions. Diagnostic significance and prognostic value in respect to pleurodesis.

Authors:  F Rodríguez-Panadero; J López Mejías
Journal:  Am Rev Respir Dis       Date:  1989-03

6.  Cells in pleural fluid. Their value in differential diagnosis.

Authors:  R W Light; Y S Erozan; W C Ball
Journal:  Arch Intern Med       Date:  1973-12

7.  Adenosine deaminase activity in pleural effusions: an aid to differential diagnosis.

Authors:  M A Piras; C Gakis; M Budroni; G Andreoni
Journal:  Br Med J       Date:  1978 Dec 23-30

8.  A prospective study of closed pleural biopsies.

Authors:  J Scerbo; H Keltz; D J Stone
Journal:  JAMA       Date:  1971-10-18       Impact factor: 56.272

9.  Metastatic carcinoma of the pleura.

Authors:  P C Meyer
Journal:  Thorax       Date:  1966-09       Impact factor: 9.139

10.  Comparison of needle biopsy with cytologic analysis for the evaluation of pleural effusion: analysis of 414 cases.

Authors:  U B Prakash; H M Reiman
Journal:  Mayo Clin Proc       Date:  1985-03       Impact factor: 7.616

View more
  2 in total

1.  Combining ADA, protein and IFN-gamma best allows discrimination between tuberculous and malignant pleural effusion.

Authors:  Y C Kim; K O Park; H S Bom; S C Lim; H K Park; H J Na; J H Park
Journal:  Korean J Intern Med       Date:  1997-06       Impact factor: 2.884

2.  The encaged lung: rapidly progressive idiopathic pleurisy.

Authors:  Ivana Castaniere; Roberto Tonelli; Riccardo Fantini; Alessandro Marchioni; Martina Garofalo; Enrico M Clini; Stefania Cerri
Journal:  Oxf Med Case Reports       Date:  2018-08-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.